Stay updated on Optune in Melanoma Brain Mets + Immune Checkpoint Inhibitors Clinical Trial
Sign up to get notified when there's something new on the Optune in Melanoma Brain Mets + Immune Checkpoint Inhibitors Clinical Trial page.

Latest updates to the Optune in Melanoma Brain Mets + Immune Checkpoint Inhibitors Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedRevision: v3.6.6 appears on the page, replacing the previous Revision: v3.6.5 in the footer, indicating a recent update to the page metadata. This update does not modify study content or visible data, but refreshes the document version tracked by the site.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page now lists sponsor and collaborators (e.g., Washington University School of Medicine and NovoCure Ltd.) and adds links to essential documents (Study Protocol and Statistical Analysis Plan) plus related terminology, expanding the contextual resources for this trial.SummaryDifference50%

- Check36 days agoChange DetectedThe page's revision tag was updated to v3.6.5, replacing v3.6.4. This indicates a minor maintenance update to the page rather than a change to study content or eligibility details.SummaryDifference0.1%

- Check51 days agoChange DetectedThe page's revision tag was updated from v3.6.3 to v3.6.4, signaling a new version of the page. This change represents an internal update to the page's versioning or display framework rather than a modification to the study data or eligibility details.SummaryDifference0.1%

- Check72 days agoChange DetectedThe page's revision tag was updated from v3.6.2 to v3.6.3, signaling a small backend/content management update. There are no changes to the study data or displayed details.SummaryDifference0.1%

- Check79 days agoChange DetectedThe page footer revision value updated from v3.6.0 to v3.6.2. This reflects a minor backend update to the page without changing content or user-facing data.SummaryDifference0.1%

Stay in the know with updates to Optune in Melanoma Brain Mets + Immune Checkpoint Inhibitors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Optune in Melanoma Brain Mets + Immune Checkpoint Inhibitors Clinical Trial page.